-
Sector Analysis
Mechanical Circulatory Support Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Mechanical Circulatory Support Devices Market Report Overview The mechanical circulatory support devices market size was valued at $933.6 million in 2023 and is forecast to grow at a CAGR of more than 3% during 2023 and 2033. Mechanical Circulatory Support Devices are devices that replace or assist the pumping function of the ventricles. Mechanical Circulatory Support Devices Market Outlook 2023-2033 ($ Million) Buy The Full Report for More Insights into The Mechanical Circulatory Support Devices Market Forecast, Download A Free...
-
Product Insights
NewHyperphosphatemia – Drugs In Development, 2024
Empower your strategies with our Hyperphosphatemia – Drugs In Development, 2024 report and make more profitable business decisions. Hyperphosphatemia is an electrolyte disorder in which there is an elevated level of phosphate in the blood. Causes include kidney failure, pseudohypoparathyroidism, hypoparathyroidism, diabetic ketoacidosis, tumor lysis syndrome, and rhabdomyolysis.[1] Diagnosis is generally based on a blood phosphate levels of greater than 1.46 mmol/L (4.5 mg/dL). Signs and symptoms include ectopic calcification, secondary hyperparathyroidism, and renal osteodystrophy. Abnormalities in phosphate metabolism such as...
-
Product Insights
NewHyperphosphatemia In Chronic Kidney Disease – Drugs In Development, 2024
Empower your strategies with our Hyperphosphatemia In Chronic Kidney Disease – Drugs In Development, 2024 report and make more profitable business decisions. Hyperphosphatemia, abnormally high serum phosphate levels, can result from increased phosphate intake, decreased phosphate excretion, or a disorder that shifts intracellular phosphate to extracellular space. This condition is most commonly seen in patients with chronic kidney disease (CKD). Signs and symptoms include fatigue, nausea, sleep disturbances, shortness of breath, bone and joint pain, pruritus, and rash. Treatment includes phosphate...
-
Product Insights
NewDilated Cardiomyopathy – Drugs In Development, 2024
Empower your strategies with our Dilated Cardiomyopathy – Drugs In Development, 2024 report and make more profitable business decisions. Dilated cardiomyopathy (DCM) is a condition in which the heart's ability to pump blood is decreased because the heart's main pumping chamber, the left ventricle, is enlarged and weakened. Symptoms include fatigue and weakness, shortness of breath (dyspnea), lightheadedness, dizziness or fainting, persistent cough or wheezing, lack of appetite, sudden weight gain from fluid retention, and swelling (edema) in legs, ankles, and...
-
Product Insights
NewCardiomyopathy – Drugs In Development, 2024
Empower your strategies with our Cardiomyopathy – Drugs In Development, 2024 report and make more profitable business decisions. Cardiomyopathy a disease of the heart muscle, where the walls of the heart chambers have become stretched, thickened or stiff. This affects the heart's ability to pump blood around the body. Most types of cardiomyopathy are inherited. It can also be caused by other conditions, or risk factors, but for some people the cause is unknown. Cardiomyopathy can affect people of all ages...
-
Product Insights
NewChronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Drugs In Development, 2024
Empower your strategies with our Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Drugs In Development, 2024 report and make more profitable business decisions. Chronic myeloid leukemia (CML), also known as chronic myelocytic leukemia, is a type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood. Risk factors for CML include high-dose radiation, age, and gender. Symptoms include weakness, fatigue, night sweats, weight loss, fever, bone pain, an enlarged spleen, and pain or a...
-
Sector Analysis
Short-Term Circulatory Support Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Short-Term Circulatory Support Devices Market Overview The short-term circulatory support devices market size was valued at $1.62 billion in 2023. The market is expected to grow at a CAGR of more than 7% during 2023-2033. An increase in healthcare spending will drive the market growth during 2023-2033. Short-term circulatory support devices are used in patients with refractory cardiogenic shock as a bridge to a decision if unresponsive to the first-line therapy. Short-Term Circulatory Support Devices Market Outlook, 2023-2033 ($ Billion)...
-
Product Insights
NewGlaucoma – Drugs In Development, 2024
Empower your strategies with our Glaucoma – Drugs In Development, 2024 report and make more profitable business decisions. Glaucoma is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow to the optic nerve. The most important risk factors include age, elevated eye pressure, African ancestry, thin cornea, and family history of glaucoma. Signs and symptoms include...